Christofer Christoforou - 15 May 2024 Form 3 Insider Report for NEVRO CORP

Role
SVP, Chief Operating Officer
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Christofer Christoforou
Issuer symbol
N/A
Transactions as of
15 May 2024
Net transactions value
$0
Form type
3
Filing time
17 May 2024, 16:40:00 UTC
Next filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVRO Common Stock 142,786 15 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVRO Stock Option (Right to Buy) 15 May 2024 Common Stock 20,000 $97.52 Direct F2
holding NVRO Stock Option (Right to Buy) 15 May 2024 Common Stock 10,000 $87.62 Direct F2
holding NVRO Stock Option (Right to Buy) 15 May 2024 Common Stock 13,000 $76.81 Direct F2
holding NVRO Stock Option (Right to Buy) 15 May 2024 Common Stock 11,000 $42.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 117,096 restricted stock units.
F2 The shares subject to the option are fully vested and exercisable.

Remarks:

Exhibit 24.1 - Power of Attorney